CG Oncology (CGON) Inventory (2025 - 2026)

CG Oncology (CGON) posted Inventory of $1.5 million for Q1 2026, down 4.6% on a QoQ basis from $1.6 million in Q4 2025.

CG Oncology (CGON) Inventory (2025 - 2026) Analysis & Trends

CG Oncology's Inventory history runs 2 years deep, the most recent figure standing at $1.5 million for Q1 2026.

Quarterly Inventory changed N/A year-over-year to $1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 million (changed N/A YoY) and the FY2025 annual result came in at $1.6 million, changed N/A from the prior year.
Inventory was $1.5 million for Q1 2026 at CG Oncology, down from $1.6 million in the prior quarter.
Across five years, Inventory topped out at $1.6 million in Q4 2025 and bottomed at $1.5 million in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Inventory (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	681.59 Mn
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	1.77 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	3.10 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	371.00 Mn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	CG Oncology	6.01 Bn	6.01 Bn	-1.88 Mn	1.49 Mn

Download Data